Biosidus
Manufacturing · Argentina · 201-500 Employees
View Company Info for Free
Overview
Headquarters
4234 Constitución 2841, Buenos Aires, Bu...Phone Number
+54 1149098000Website
www.biosidus.com.arRevenue
$82.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Biosidus
Biosidus is a leader in biosimilars within emerging markets, particularly in Latin America, with a growing presence in Asia, Africa, and Eastern Europe. The company is committed to maintaining international quality standards in its processes and products, aimed at ensuring patient health. Additionally, Biosidus offers patient support programs and prioritizes pharmacovigilance. Celebrating its 40th anniversary in 2023, the company continues to innovate and lead in biotechnology applied to human health.Explore more
Biosidus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biosidus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Biosidus launches new products
Earning: See what the market has to say on Biosidus recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Biosidus had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Biosidus has new funding data
Check if Biosidus has recently received funding, and reach out quickly before it becomes old news!
Biosidus, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Biosidus is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Biosidus
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Biosidus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biosidus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biosidus.
Biosidus Tech Stack
A closer look at the technologies used by Biosidus
See more technologies
Biosidus News & Media
Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
BUENOS AIRES, Argentina, Aug. 26, 2026 /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company's...Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
BUENOS AIRES, Argentina, Aug. 27, 2026 /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company's biologics production capacity and reinforcing its ability to support potential international demand. Biosidus works to improve people's quality of life. The expansion strengthens Biosidus' industrial platform atBiosidus Expands its International Footprint Through Strategic Partnership with Mubadala Bio in the UAE
SAN DIEGO and BUENOS AIRES, Argentina, June 24, 2026 /PRNewswire/ -- Biosidus, one of Latin America's pioneering biotechnology companies, announced the signing of a licensing and supply agreement with Mubadala Bio, the life sciences platform of Mubadala Investment Company, to introduce a...Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America
SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar development and commercialization, for the commercialization of Tuznue® (trastuzumab) across Latin American markets, including Argentina, Mexico, Bolivia, and Paraguay. Tuznue® is a biosimilar
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biosidus
Sign Up For FreeTo access detailed company insights
Biosidus is a leader in biosimilars within emerging markets, particularly in Latin America, with a growing presence in Asia, Africa, and Eastern Europe. The company is committed to maintaining international quality standards in its processes and products, aimed at ensuring patient health. Additionally, Biosidus offers patient support programs and p... Read More
